Vera Therapeutics Book Value Per Share Growth & History (VERA)
Vera Therapeutics's book value per share was $8.48 for fiscal 2025.
View full Vera Therapeutics company overviewVera Therapeutics annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $8.48 | -$0.60 | −6.59% |
| 2024 | 2024-12-31 | $9.08 | $6.79 | +296.96% |
| 2023 | 2023-12-31 | $2.29 | -$0.48 | −17.31% |
| 2022 | 2022-12-31 | $2.77 | -$2.41 | −46.59% |
| 2021 | 2021-12-31 | $5.18 | $284.42 | — |
| 2020 | 2020-12-31 | -$279.24 | — | — |
Vera Therapeutics quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $5.66 | -$1.68 | −22.88% |
| Q1 2026 | 2026-03-31 | $6.96 | -$1.43 | −17.02% |
| Q4 2025 | 2025-12-31 | $8.48 | — | — |
| Q3 2025 | 2025-09-30 | $6.24 | $1.67 | +36.69% |
| Q2 2025 | 2025-06-30 | $7.34 | $1.36 | +22.69% |
| Q1 2025 | 2025-03-31 | $8.39 | $1.93 | +29.80% |
| Q3 2024 | 2024-09-30 | $4.56 | $1.78 | +63.96% |
| Q2 2024 | 2024-06-30 | $5.98 | $2.81 | +88.60% |
| Q1 2024 | 2024-03-31 | $6.46 | $2.90 | +81.39% |
| Q3 2023 | 2023-09-30 | $2.78 | -$1.04 | −27.16% |
| Q2 2023 | 2023-06-30 | $3.17 | -$1.32 | −29.34% |
| Q1 2023 | 2023-03-31 | $3.56 | -$1.99 | −35.78% |
| Q3 2022 | 2022-09-30 | $3.82 | -$0.20 | −4.90% |
| Q2 2022 | 2022-06-30 | $4.49 | -$4.29 | −48.87% |
| Q1 2022 | 2022-03-31 | $5.55 | $247.68 | — |
| Q3 2021 | 2021-09-30 | $4.02 | — | — |
| Q2 2021 | 2021-06-30 | $8.78 | — | — |
| Q1 2021 | 2021-03-31 | -$242.13 | — | — |
Vera Therapeutics book value per share trends
Over the last five fiscal years, Vera Therapeutics's book value per share increased from -$279.24 to $8.48, a change of $287.73. The latest reported quarter, Q2 2026, shows $5.66.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Vera Therapeutics source filings ↗